Latest Form 4 insider transactions

Leslie Li Hsien Chang, a Director of Canadian Solar Inc., reported multiple transactions in common stock on October 6, 2026.

Derek J Maetzold, Pres. & Chief Exec. Officer and a Director of Castle Biosciences Inc, sold 14,496 shares of common stock on October 5, 2026 for $35.57 per share.

Michael H Thaman, a Director of UL Solutions Inc., received 444 shares of common stock on October 5, 2026.

Richard A Meier, a Director of Accuray Inc, reported multiple transactions in common stock on October 5, 2026.

Nima Ghamsari, HEAD OF BLEND and a Director of Blend Labs, Inc., sold 24,272 shares of common stock on October 5, 2026 for $1.02 per share.

Bradley E. Smith, a Director of Tiptree Inc., received 1,807 shares of common stock on October 6, 2026.

Roger Sawhney, a Director of Arbutus Biopharma Corp, reported a transaction in 17,142 shares of common stock on October 1, 2026.

Lindsay Androski, President and CEO and a Director of Arbutus Biopharma Corp, reported a transaction in 24,655 shares of common stock on October 1, 2026.

Matthew W Cooper, General Counsel & Corp Secy of Capital One Financial Corp, sold 3,500 shares of common stock on October 6, 2026 for $196.22 per share.

Darcie M. Cakaric, SEVP and Chief HR Officer of At&T Inc., reported multiple transactions in common stock on October 6, 2026.

Jim Wassil, EVP, Chief Scientific Ofc, COO of Vaxcyte, Inc., sold 18,000 shares of common stock on October 5, 2026 for $86.74 per share.

Vikram Kini, a Director of UL Solutions Inc., received 278 shares of common stock on October 5, 2026.

Lesley Goldwasser, a Director of Tiptree Inc., received 1,084 shares of common stock on October 6, 2026.

Jeremy Prahm, Chief Investment Officer of Finance of America Companies Inc., sold 6,000 shares of common stock on October 5, 2026 for $13.20 per share.

Elvia Cowan, SVP, Finance & CAO of Vaxcyte, Inc., sold 19,000 shares of common stock on October 5, 2026 for $86.74 per share.

Michelle Elizabeth Caron, Chief Financial Officer of A10 Networks, Inc., reported a transaction in 1,743 shares of common stock on October 5, 2026.

Mary C Henry, a Director of A10 Networks, Inc., received 7,981 shares of common stock on October 5, 2026.

Jason J. Armstrong, Chief Financial Officer of Clean Energy Fuels Corp., received 35,000 shares of common stock on October 6, 2026.

John T Hall, Chief Executive Officer and a Director of Intapp, Inc., sold 3,000 shares of common stock on October 5, 2026 for $36.50 per share.

IRT Acquisition Corp. has scheduled a special meeting for shareholders to vote on a proposed business combination with a target entity, signaling a significant step towards a potential merger.

IRT Acquisition Corp. has scheduled a special meeting for shareholders to vote on a proposed business combination with a target entity, signaling a significant step towards a potential merger.

Yufan Stephanie Wang, Chief Legal Officer of Progress Software Corp /Ma, sold 1,245 shares of common stock on October 5, 2026 for $37.00 per share.

D Scott Coward, a Director of Humacyte, Inc., received 125,000 shares of common stock on October 6, 2026.

William C Bayless Jr, a Director of Pebblebrook Hotel Trust, received 2,658 shares of common stock on October 1, 2026.

Harry E Ruda, a Director of Canadian Solar Inc., reported multiple transactions in common stock on October 6, 2026.

Emily M. Leproust, Chief Executive Officer and a Director of Twist Bioscience Corp, sold 4,548 shares of common stock on October 5, 2026.

Paul Brian Kuznik, a Director of Humacyte, Inc., received 125,000 shares of common stock on October 6, 2026.

Shu-Hua (Joshua) Yeh, *** See Remarks of Applied Optoelectronics, Inc., sold 6,000 shares of common stock on October 5, 2026 for $120.03 per share.

James M Mock, Chief Financial Officer of Moderna, Inc., reported multiple transactions in common stock on October 5, 2026.

Well Daan Van, Chief Legal Officer of SOPHiA GENETICS SA, sold 6,168 shares of common stock on October 5, 2026 for $8.12 per share.